BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25696601)

  • 1. Glucose and potassium derangements by glucose-insulin-potassium infusion in acute myocardial infarction.
    van der Horst IC; Timmer JR; Ottervanger JP; Bilo HJ; Miedema K; Gans RO; de Boer MJ; Vogelzang M; Nijsten MW; Zijlstra F
    Neth Heart J; 2006 Mar; 14(3):89-94. PubMed ID: 25696601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion.
    van der Horst IC; De Luca G; Ottervanger JP; de Boer MJ; Hoorntje JC; Suryapranata H; Dambrink JH; Gosselink AT; Zijlstra F; van 't Hof AW
    Am Heart J; 2005 Jun; 149(6):1135. PubMed ID: 15976800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II.
    Rasoul S; Ottervanger JP; Timmer JR; Svilaas T; Henriques JP; Dambrink JH; van der Horst IC; Zijlstra F
    Int J Cardiol; 2007 Oct; 122(1):52-5. PubMed ID: 17223212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
    Mehta SR; Yusuf S; Díaz R; Zhu J; Pais P; Xavier D; Paolasso E; Ahmed R; Xie C; Kazmi K; Tai J; Orlandini A; Pogue J; Liu L;
    JAMA; 2005 Jan; 293(4):437-46. PubMed ID: 15671428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.
    van der Horst IC; Zijlstra F; van 't Hof AW; Doggen CJ; de Boer MJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gans RO; Bilo HJ;
    J Am Coll Cardiol; 2003 Sep; 42(5):784-91. PubMed ID: 12957421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
    Díaz R; Goyal A; Mehta SR; Afzal R; Xavier D; Pais P; Chrolavicius S; Zhu J; Kazmi K; Liu L; Budaj A; Zubaid M; Avezum A; Ruda M; Yusuf S
    JAMA; 2007 Nov; 298(20):2399-405. PubMed ID: 18042917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction.
    Bucciarelli-Ducci C; Bianchi M; De Luca L; Battagliese A; Di Russo C; Proietti P; Vizza CD; Fedele F
    Am J Cardiol; 2006 Nov; 98(10):1349-53. PubMed ID: 17134627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy.
    Krljanac G; Vasiljević Z; Radovanović M; Stanković G; Milić N; Stefanović B; Kostić J; Mitrović P; Radovanović N; Dragović M; Marinković J; Karadzić A
    Am J Cardiol; 2005 Oct; 96(8):1053-8. PubMed ID: 16214437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion.
    Rogers WJ; Stanley AW; Breinig JB; Prather JW; McDaniel HG; Moraski RE; Mantle JA; Russell RO; Rackley CE
    Am Heart J; 1976 Oct; 92(4):441-54. PubMed ID: 785990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616].
    van der Horst IC; Ottervanger JP; van 't Hof AW; Reiffers S; Miedema K; Hoorntje JC; Dambrink JH; Gosselink AT; Nijsten MW; Suryapranata H; de Boer MJ; Zijlstra F
    BMC Med; 2005 Jun; 3():9. PubMed ID: 15932638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glucose-insulin-potassium infusion on QT dispersion in patients with acute myocardial infarction.
    Wolk R; Lusawa T; Ceremuzynski L
    Ann Noninvasive Electrocardiol; 2001 Jan; 6(1):50-4. PubMed ID: 11174863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative analysis of the effect of glucose-insulin-potassium in acute myocardial infarction.
    Rasoul S; Svilaas T; Ottervanger JP; Timmer JR; van 't Hof AW; Zijlstra F
    Neth Heart J; 2006 Jan; 14(1):19-23. PubMed ID: 25696550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction.
    Chaudhuri A; Janicke D; Wilson M; Ghanim H; Wilding GE; Aljada A; Dandona P
    Am J Cardiol; 2007 Dec; 100(11):1614-8. PubMed ID: 18036357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization.
    Yazici M; Demircan S; Durna K; Yasar E; Acar Z; Sahin M
    Am J Cardiol; 2005 Dec; 96(11):1517-20. PubMed ID: 16310433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial.
    Ceremuzyński L; Budaj A; Czepiel A; Burzykowski T; Achremczyk P; Smielak-Korombel W; Maciejewicz J; Dziubińska J; Nartowicz E; Kawka-Urbanek T; Piotrowski W; Hanzlik J; Cieśliński A; Kawecka-Jaszcz K; Gessek J; Wrabec K
    Cardiovasc Drugs Ther; 1999 May; 13(3):191-200. PubMed ID: 10439881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
    Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-insulin-potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms.
    Timmer JR; van der Horst IC; Ottervanger JP; De Luca G; van 't Hof AW; Bilo HJ; Zijlstra F
    Ital Heart J; 2004 Oct; 5(10):727-31. PubMed ID: 15626267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose glucose-insulin-potassium has hemodynamic benefits and can improve cardiac remodeling in acute myocardial infarction treated with primary percutaneous coronary intervention: From a randomized controlled study.
    Li Y; Zhang L; Zhang L; Zhang H; Zhang N; Yang Z; Gao M; Yang X; Cui L
    J Cardiovasc Dis Res; 2010 Jul; 1(3):104-9. PubMed ID: 21187862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of low-dose dobutamine stress echocardiography and echocardiography during glucose-insulin-potassium infusion for detection of myocardial viability after anterior myocardial infarction.
    Yetkin E; Senen K; Ileri M; Atak R; Tandogan I; Yetkin O; Kosar F; Turhan H; Cehreli S
    Coron Artery Dis; 2002 May; 13(3):145-9. PubMed ID: 12131017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction.
    Bedetti G; Pizzi C; Gabrieli L; Varga A; Pasanisi E; Bugiardini R; Picano E
    Int J Cardiol; 2005 Jul; 102(2):255-8. PubMed ID: 15982493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.